ACAD
32.86
+0.56
+1.73%
AEMD
5.3
-0.05
-0.93%
APRI
0.34
0.00
-0.15%
ARNA
1.63
0.00
0.00%
ATEC
3.692
+0.092
+2.556%
CNAT
1.9
-0.04
-2.06%
CRXM
0.168
0.00
0.00%
CYTX
2.05
+0.02
+0.99%
DXCM
91.24
+0.62
+0.68%
GNMK
8.75
+0.01
+0.11%
HALO
9.82
+0.27
+2.83%
ILMN
172.21
+2.73
+1.61%
INNV
0.27
-0.13
-32.50%
INO
8.86
+0.19
+2.19%
ISCO
1.95
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
103.55
-0.1
-0.10%
LPTN
2.75
-0.07
-2.48%
MBVX
5.07
-0.02
-0.34%
MEIP
1.91
-0.07
-3.54%
MNOV
6.17
-0.25
-3.89%
MRTX
5.09
+0.11
+2.21%
MSTX
0.39
-0.01
-1.49%
NBIX
49.54
+0.6
+1.23%
NUVA
64.07
+0.68
+1.07%
ONCS
1.7
-0.02
-1.16%
ONVO
3.88
-0.02
-0.51%
OREX
3.85
+0.03
+0.79%
OTIC
16.01
+0.33
+2.10%
QDEL
21.59
+0.17
+0.79%
RCPT
231.96
0.00
0.00%
RGLS
3.24
+0.08
+2.53%
RMD
69.03
+0.59
+0.86%
SPHS
3.52
+0.02
+0.57%
SRNE
6.62
+0.06
+0.91%
TROV
5
+0.08
+1.63%
VICL
3.99
+0.14
+3.64%
VOLC
18
0.00
0.00%
ZGNX
9.29
+0.21
+2.31%
ACAD
32.86
+0.56
+1.73%
AEMD
5.3
-0.05
-0.93%
APRI
0.34
0.00
-0.15%
ARNA
1.63
0.00
0.00%
ATEC
3.692
+0.092
+2.556%
CNAT
1.9
-0.04
-2.06%
CRXM
0.168
0.00
0.00%
CYTX
2.05
+0.02
+0.99%
DXCM
91.24
+0.62
+0.68%
GNMK
8.75
+0.01
+0.11%
HALO
9.82
+0.27
+2.83%
ILMN
172.21
+2.73
+1.61%
INNV
0.27
-0.13
-32.50%
INO
8.86
+0.19
+2.19%
ISCO
1.95
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
103.55
-0.1
-0.10%
LPTN
2.75
-0.07
-2.48%
MBVX
5.07
-0.02
-0.34%
MEIP
1.91
-0.07
-3.54%
MNOV
6.17
-0.25
-3.89%
MRTX
5.09
+0.11
+2.21%
MSTX
0.39
-0.01
-1.49%
NBIX
49.54
+0.6
+1.23%
NUVA
64.07
+0.68
+1.07%
ONCS
1.7
-0.02
-1.16%
ONVO
3.88
-0.02
-0.51%
OREX
3.85
+0.03
+0.79%
OTIC
16.01
+0.33
+2.10%
QDEL
21.59
+0.17
+0.79%
RCPT
231.96
0.00
0.00%
RGLS
3.24
+0.08
+2.53%
RMD
69.03
+0.59
+0.86%
SPHS
3.52
+0.02
+0.57%
SRNE
6.62
+0.06
+0.91%
TROV
5
+0.08
+1.63%
VICL
3.99
+0.14
+3.64%
VOLC
18
0.00
0.00%
ZGNX
9.29
+0.21
+2.31%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …